Jordan Hale

Jordan Hale is a senior markets analyst at The Scope covering U.S. equities, earnings, and global macro. His work focuses on translating sell-side consensus and price action into clear, data-driven takeaways for individual investors.

AVGO Stock: Is Broadcom Still Undervalued After Its AI Deals? | Senior Analyst Report

by

Broadcom Inc. (NASDAQ: AVGO) has transformed from a diversified semiconductor stalwart into a dominant force in artificial intelligence infrastructure, a shift that has sent its valuation soaring. The company’s latest earnings reports reveal a staggering acceleration in AI-related revenue, driven by its custom silicon deals with hyperscalers and its leadership in high-speed networking. Yet, as … Read more

QCOM Stock Drop Explained: Why It Fell Nearly 8% After an Earnings Miss and Weak Outlook | Senior Analyst Report

by

A revenue beat wasn’t enough to save Qualcomm (QCOM) from a sharp post-earnings selloff, with shares plunging after the company delivered a mixed fiscal third-quarter report and a downbeat outlook. The results laid bare the intense pressure on its core handset business, forcing investors to weigh the promise of long-term diversification against the pain of … Read more

The Federal Reserve Held Rates Steady. Equities Fell, Bond Yields Surged, and the Dollar Sank Anyway. | Macro Analysis

by

The market wanted a dovish hold and got a hawkish pause instead. The Federal Reserve’s decision to keep its benchmark interest rate in a 3.50% to 3.75% range was widely anticipated, but the details of the announcement revealed a central bank grappling with internal division and external shocks, leaving investors with more questions than answers. … Read more

AAPL Q3 Earnings Preview: Did Price Hikes Boost Mac and iPad Revenue? | Senior Analyst Report

by

With its stock trading near all-time highs, Apple heads into its fiscal Q3 2026 earnings report on July 30 with considerable investor expectations. The narrative has shifted from mere iPhone unit sales to a more complex story involving high-margin Services growth, a capital-light approach to AI, and a crucial test of its pricing power. The … Read more

SKHY Stock Drop Explained: Why It Fell On Record Profit That Missed Lofty AI Expectations | Senior Analyst Report

by

📋 Desk Briefing SK Hynix just delivered a masterclass in market paradox. The company announced its best quarter in history, with operating profit soaring an incredible 557% year-over-year to ₩60.5 trillion (approximately $41.6B USD), yet its stock stumbled. The reason is simple but brutal: in the supercharged AI era, even record-breaking is not enough if … Read more

The Street Is Betting On a Hawkish Fed Outlook. The Greenback Is Predicted To Tumble Anyway. | Macro Analysis

by

The consensus is clear: the Federal Reserve is in a hawkish mood, with markets pricing in the potential for more rate hikes this year to tame persistent inflation. Yet, in a counterintuitive twist that has global strategists on edge, the US Dollar Index (DXY), after a period of strength, is facing predictions of a sustained … Read more

Uber Is Near a 52-Week Low. Wall Street Says Buy Anyway. | Senior Analyst Report

by

📋 Desk Briefing Uber’s (UBER) stock is telling a tale of two markets. While shares recently touched a 52-week low of $65.41, a significant retreat from its high of $101.99, the analyst community remains steadfastly bullish. This disconnect presents a critical question for investors: is the current price a deep value opportunity or a warning … Read more

Microsoft’s $190 Billion AI Bet: Is Azure Keeping Up? | Senior Analyst Report

by

📋 Desk Briefing Microsoft is making an existential bet on artificial intelligence, committing to a capital expenditure plan of roughly $190 billion for calendar year 2026 alone. This staggering figure, up 61% from the previous year, is being poured into a global buildout of AI-optimized data centers designed to power the next generation of enterprise … Read more

Inflation was expected to ease policy pressure. The European Central Bank remains on track for another hike anyway. | Macro Analysis

by

Markets read the script and saw a plot twist. With Eurozone inflation showing signs of cooling, the consensus expected central bank pressure to ease. Yet, the European Central Bank (ECB) is holding a hawkish line, signaling that the fight is far from over and keeping a September rate hike firmly on the table. Eurozone Inflation … Read more

AstraZeneca Beats Q2 Earnings: Deep Dive on a Pharma Giant at a Crossroads

by

AstraZeneca (AZN) just blew past second-quarter earnings estimates, but the market’s reaction has been tempered. The pharmaceutical giant’s success story has long been one of relentless pipeline execution and oncology dominance. Now, after a rare and high-profile clinical trial failure, investors are starting to ask tougher questions about the sustainability of its growth and its … Read more